TY - JOUR
T1 - Conventional anticonvulsant drugs in the guinea pig kindling model of partial seizures
T2 - Effects of acute phenobarbital, valproate, and ethosuximide
AU - Gilbert, Trevor H.
AU - Corley, Shannon M.
AU - Teskey, G. Campbell
N1 - Funding Information:
Acknowledgements This study was supported by an NSERC research grant and Social Science Research Fellowship awarded to G.C.T., and a scholarship from NSERC awarded to T.H.G. We thank Kaley Bellward, Marie Monfils, Shelaine Moore, Heather Lawrence, and Connie Legare for technical assistance.
PY - 2002
Y1 - 2002
N2 - This study addressed the anticonvulsant effects of phenobarbital, valproate, and ethosuximide in the amygdala of kindled guinea pigs to further validate this model for the screening of anticonvulsant drugs. Behavioral toxic effects were assessed at 30 min following drug administration using quantitative locomotor tests, as well as scores on a sedation and muscle relaxation rating index. The anticonvulsant efficacy of the drugs were evaluated from measurements of afterdischarge threshold (ADT), afterdischarge duration (ADD), and behavioral seizure severity (SS) during early and late phases of kindling acquisition, and in kindled guinea pigs. ADD and SS were also measured in response to both threshold and suprathreshold kindling stimulation. All drugs exerted slight to moderate sedative effects in guinea pigs on both the behavioral tests and rating index. We found that phenobarbital exhibited effective anticonvulsant properties in guinea pigs by consistently reducing ADD and SS in response to both threshold and suprathreshold kindling stimulation. Valproate exhibited effective anticonvulsant properties at threshold stimulation and less effective properties at suprathreshold stimulation. Lastly, we found that ethosuximide lacked effective anticonvulsant action at either threshold or suprathreshold kindling stimulation. Our results indicate that the guinea pig kindling model correctly predicted the actions of phenobarbital, valproate, and ethosuximide in the treatment of partial seizures. Guinea pig amygdala kindling appears to serve as a useful and valid model for partial epilepsy.
AB - This study addressed the anticonvulsant effects of phenobarbital, valproate, and ethosuximide in the amygdala of kindled guinea pigs to further validate this model for the screening of anticonvulsant drugs. Behavioral toxic effects were assessed at 30 min following drug administration using quantitative locomotor tests, as well as scores on a sedation and muscle relaxation rating index. The anticonvulsant efficacy of the drugs were evaluated from measurements of afterdischarge threshold (ADT), afterdischarge duration (ADD), and behavioral seizure severity (SS) during early and late phases of kindling acquisition, and in kindled guinea pigs. ADD and SS were also measured in response to both threshold and suprathreshold kindling stimulation. All drugs exerted slight to moderate sedative effects in guinea pigs on both the behavioral tests and rating index. We found that phenobarbital exhibited effective anticonvulsant properties in guinea pigs by consistently reducing ADD and SS in response to both threshold and suprathreshold kindling stimulation. Valproate exhibited effective anticonvulsant properties at threshold stimulation and less effective properties at suprathreshold stimulation. Lastly, we found that ethosuximide lacked effective anticonvulsant action at either threshold or suprathreshold kindling stimulation. Our results indicate that the guinea pig kindling model correctly predicted the actions of phenobarbital, valproate, and ethosuximide in the treatment of partial seizures. Guinea pig amygdala kindling appears to serve as a useful and valid model for partial epilepsy.
KW - Afterdischarge threshold
KW - Antiepileptic drugs
KW - Behavioral toxicity
KW - Epilepsy
KW - Guinea pig
KW - Seizures
UR - http://www.scopus.com/inward/record.url?scp=0036383396&partnerID=8YFLogxK
U2 - 10.1007/s00221-002-1183-9
DO - 10.1007/s00221-002-1183-9
M3 - Journal Article
C2 - 12232690
AN - SCOPUS:0036383396
SN - 0014-4819
VL - 146
SP - 336
EP - 344
JO - Experimental Brain Research
JF - Experimental Brain Research
IS - 3
ER -